Desmopressin Nasal Spray — Class II drug recall D-0510-2026
Ongoing recall by Apotex Corp., reported 2026-04-22, distributed nationwide. Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
| Recall number | D-0510-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apotex Corp., Weston, FL, United States |
| Recall initiated | 2026-04-08 |
| Classified | 2026-05-01 |
| Reported by FDA | 2026-04-22 |
| Distributed | Nationwide (US) |
| Reason classes | packaging |
| NDC | 60505-0815-00 |
| Lot numbers | VM4231 |
| Expiration dates | 2027-06-30 |
Product
Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
Reason for recall
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0510-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.